Drug safety. Gaps in the safety net
- PMID: 15653480
- DOI: 10.1126/science.307.5707.196
Drug safety. Gaps in the safety net
Comment in
-
Comparative studies of drug efficacy.Science. 2005 Apr 8;308(5719):202-3. doi: 10.1126/science.308.5719.202. Science. 2005. PMID: 15821072 No abstract available.
-
Does the dose make the poison?Science. 2005 Apr 8;308(5719):203. doi: 10.1126/science.308.5719.203a. Science. 2005. PMID: 15821073 No abstract available.
Similar articles
-
Importance and challenges of studying marketed drugs: what is a phase IV study? Common clinical research designs, registries, and self-reporting systems.J Clin Pharmacol. 2007 Sep;47(9):1074-86. doi: 10.1177/0091270007304776. J Clin Pharmacol. 2007. PMID: 17766697
-
Cause and effect? Assessing postmarketing safety studies as evidence of causation in products liability cases.Food Drug Law J. 2007;62(3):445-72. Food Drug Law J. 2007. PMID: 17915388 No abstract available.
-
FDA attempting to overcome major roadblocks in monitoring drug safety.J Natl Cancer Inst. 2005 Jun 15;97(12):872-3. doi: 10.1093/jnci/97.12.872. J Natl Cancer Inst. 2005. PMID: 15956645 No abstract available.
-
Postmarketing surveillance and reporting of adverse drug events.S D J Med. 2004 Jan;57(1):13-4. S D J Med. 2004. PMID: 14964975 Review. No abstract available.
-
Post-market approval surveillance: a call for a more integrated and comprehensive approach.Circulation. 2004 Jun 29;109(25):3073-7. doi: 10.1161/01.CIR.0000134694.78653.B6. Circulation. 2004. PMID: 15226222 Review. No abstract available.
Cited by
-
Improving the reporting of adverse drug reactions: a cluster-randomized trial among pharmacists in Portugal.Drug Saf. 2008;31(4):335-44. doi: 10.2165/00002018-200831040-00007. Drug Saf. 2008. PMID: 18366244 Clinical Trial.
-
A secure distributed logistic regression protocol for the detection of rare adverse drug events.J Am Med Inform Assoc. 2013 May 1;20(3):453-61. doi: 10.1136/amiajnl-2011-000735. Epub 2012 Aug 7. J Am Med Inform Assoc. 2013. PMID: 22871397 Free PMC article.
-
Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases.J Am Med Inform Assoc. 2010 Nov-Dec;17(6):652-62. doi: 10.1136/jamia.2009.002477. J Am Med Inform Assoc. 2010. PMID: 20962127 Free PMC article.
-
Personalized medicine: a reality within this decade.J Cardiovasc Transl Res. 2008 Mar;1(1):11-6. doi: 10.1007/s12265-007-9001-1. Epub 2008 Jan 26. J Cardiovasc Transl Res. 2008. PMID: 20559952 Review.
-
Beyond post-marketing research and MedWatch: Long-term studies of drug risks.Drug Des Devel Ther. 2007 Oct 1;1:1-5. doi: 10.2147/dddt.s2352. Drug Des Devel Ther. 2007. PMID: 19727333 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources